Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
SIA-CAE Pilot Training JV in Singapore to Commence Operations

2018-07-20 asdnews
Singapore Airlines (SIA) and CAE (NYSE: CAE; TSX: CAE) announced today that they will launch operations of their new Singapore CAE Flight Training Pte. Ltd. (SCFT) joint venture for pilot training in Singapore next month. SIA and CAE have concluded the establishment of the joint venture company and all regulatory approvals have been obtained. Plans for the joint venture were announced in August last year, when a Memorandum of Understanding was signed.
C6L CAE SINGY CAE SINGF

0
La coentreprise de Singapore Airlines et CAE pour la formation des pilotes débutera ses activités à Singapour

2018-07-18 globenewswire
SINGAPOUR, 18 juill. 2018 (GLOBE NEWSWIRE) -- Singapore Airlines (SIA) et CAE (NYSE:CAE) (TSX:CAE) ont annoncé aujourd’hui que leur nouvelle coentreprise Singapore CAE Flight Training Pte Ltd. (SCFT) qui assurera la formation des pilotes à Singapour amorcera ses activités le mois prochain. SIA et CAE ont conclu l’entente de coentreprise et obtenu toutes les approbations réglementaires requises pour réaliser la transaction.
MLYAF C6L CAE SINGY CAE SINGF

0
SIA-CAE pilot training joint venture in Singapore to commence operations

2018-07-18 globenewswire
SINGAPORE, July 18, 2018 (GLOBE NEWSWIRE) -- Singapore Airlines (SIA) and CAE (NYSE:CAE) (TSX:CAE) announced today that they will launch operations of their new Singapore CAE Flight Training Pte. Ltd. (SCFT) joint venture for pilot training in Singapore next month. SIA and CAE have concluded the establishment of the joint venture company and all regulatory approvals have been obtained. Plans for the joint venture were announced in August last year, when a Memorandum of Understanding was signed.
MLYAF C6L CAE SINGY CAE SINGF

0
CAE Growth Drivers

2018-07-18 seekingalpha
The Department of Defense is going to look for simulation to save money on flights in order to squire new aircraft.
CAE BA

0
CAE Launches CAE 700MR Series Flight Training Device for Military Helicopter Training

2018-07-16 asdnews
Today at the Farnborough International Airshow, CAE announced the launch of the CAE 700MR Series flight training device (FTD), a next-generation FTD designed specifically for military helicopter flight and mission training.
CAE

0
CAE signs commercial aviation training solutions contract with Qatar Airways, including the world’s second airline-operated Boeing 777X full-flight simulator

2018-07-16 globenewswire
FARNBOROUGH, United Kingdom, July 16, 2018 (GLOBE NEWSWIRE) -- (NYSE:CAE) (TSX:CAE) – CAE announced today at the 2018 Farnborough Airshow that it has sold five (5) CAE-built full-flight simulators (FFSs) – 3x Boeing 777X and 2x Boeing 737MAX – and two (2) flight training devices (FTDs) – one Boeing 777X and one Boeing 737MAX to support the growing pilot training needs of the airline. This order includes the world’s second airline-operated Boeing 777X full-flight simulator (FFS).
CAE CAE

0
Altair: Competing In A Fast Growth Market With Edge

2018-07-03 seekingalpha
Top notch recurring software license rate and revenue expansion within existing customer base indicates true organic growth.
CAE

5
CAE / CAE Inc. FORM 6K (Current Report of Foreign Issuer)

2018-06-29 sec.gov
CAE - Notice of Annual Meeting of Shareholders and 2018 Management Proxy Circular SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of: June
CAE

5
CAE / CAE Inc. FORM 40-F

2018-06-29 sec.gov
form40-fsigned.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION
CAE

5
CAE / CAE Inc. FORM 6-K AND 2018 ANNUAL REPORT (Current Report of Foreign Issuer)

2018-06-29 sec.gov
ksignedjune2918.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
CAE

5
CAE, Inc. workers in Montreal striking

2018-06-25 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
CAE

5
Airlines struggle with pilot shortage

2018-06-18 perthnow.com.au
A GROWING shortage of airline pilots is putting the industry's recent growth at risk as planes sit idle, higher salaries cut into profits and unions across the globe push for more benefits.
CAE

10
Airlines struggle with global pilot shortage - Channel NewsAsia

2018-06-06 channelnewsasia
A growing shortage of airline pilots is putting the industry's recent growth at risk as planes sit idle, higher salaries cut into profits and unions across the globe push for more benefits.
QABSD ACDVF CAE QABSY QUBSF QAN AC

10
Airlines struggle with global pilot shortage

2018-06-06 reuters
SYDNEY/BANGKOK/MONTREAL (Reuters) - A growing shortage of airline pilots is putting the industry’s recent growth at risk as planes sit idle, higher salaries cut into profits and unions across the globe push for more benefits.
QABSD ACDVF CAE QABSY QUBSF QAN AC

5
CAE / CAE Inc. FORM SD

2018-05-31 sec.gov
formsdsignedmay31-18.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
CAE

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to CAE / CAE Inc. on message board site Silicon Investor.

Caeser Entertainment Inc. CAE Industries
Moldflow Corporation (MFLO) - Plastic CAE Market Leader HCCAE
CAER. whatu0027s up.
CUSIP: 124765108